Target intelligence / Profile preview

WW domain-containing E3 ubiquitin protein ligase 2 pseudogene (LOC100421870)

Target
LOC100421870
Molecular classification
Pseudogene, Noncoding RNA
01

Overview

WW domain-containing E3 ubiquitin protein ligase 2 pseudogene (LOC100421870) is a genomic segment resembling the functional gene encoding the WW domain-containing E3 ubiquitin protein ligase. As a pseudogene, it does not produce a functional protein product. Most pseudogenes, including LOC100421870, are considered nonfunctional DNA remnants, though some pseudogenes are transcribed and may participate in regulatory RNA pathways, such as acting as microRNA decoys or producing small interfering RNAs that modulate expression of related genes. Pseudogenes occasionally exhibit tissue-specific transcription and have been implicated in the regulation of coding genes in cancer and other conditions; however, in the case of LOC100421870, there is no evidence of direct biological or pathological function, drug interaction, or therapeutic relevance[1][2][3]. To summarize, LOC100421870 (ENSG00000233724) is a pseudogene, not a standard protein-coding gene or target, and should not be considered a therapeutic or pharmacological target[2][3].

Other names
LOC100421870WW domain containing E3 ubiquitin protein ligase 2 pseudogeneGC10U901409GC10M067008
02

Biological functions

Possible regulation of gene expression via noncoding RNA mechanisms (such as acting as microRNA decoys, or being processed into siRNAs)No direct protein function
03

Disease associations

Some pseudogenes are deregulated in cancer and can affect tumor suppressors or oncogenesNo direct disease association or therapeutic relevance confirmed for LOC100421870

Beyond the preview

Go deeper on WW domain-containing E3 ubiquitin protein ligase 2 pseudogene (LOC100421870).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on WW domain-containing E3 ubiquitin protein ligase 2 pseudogene (LOC100421870).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call